Reading Time: 2 minutes While a CRL is a rejection of the NDA in its current form, it’s not
Reading Time: < 1 minute In this Issue Dan Crenshaw and Elon Musk Add Fuel to Lykos ‘Dumpster Fire’ Drama
Reading Time: < 1 minute Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development
Reading Time: < 1 minute In this Issue Sergey Brin Bets $15M on Ibogaine Startup Soneira, But Questions Loom Over
Reading Time: < 1 minute Coverage by Oliver Longstaff for Pα+, edited by Josh Hardman. Last month, we learned that
Reading Time: 5 minutes In this Issue California’s Psychedelic Research Bottleneck Ends Today Letter to the Editor: Neşe Devenot
Reading Time: < 1 minute Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development
Reading Time: 3 minutes In this Issue Lykos Insiders, Affiliates, Respond to Critics Might FDA Miss Its August 11th
Reading Time: 3 minutes Facilitator Licensing & TrainingDORA’s first set of rules, released in April, mark the first rules
Reading Time: 5 minutes Hardman: So you originally were focusing on Sweden, but now you have broadened that remit